Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
21.00
-0.77 (-3.54%)
Nov 17, 2025, 2:56 PM EST - Market open
Phreesia Revenue
Phreesia had revenue of $117.26M in the quarter ending July 31, 2025, with 14.83% growth. This brings the company's revenue in the last twelve months to $449.67M, up 15.31% year-over-year. In the fiscal year ending January 31, 2025, Phreesia had annual revenue of $419.81M with 17.83% growth.
Revenue (ttm)
$449.67M
Revenue Growth
+15.31%
P/S Ratio
2.84
Revenue / Employee
$215,981
Employees
2,082
Market Cap
1.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 419.81M | 63.51M | 17.83% |
| Jan 31, 2024 | 356.30M | 75.39M | 26.84% |
| Jan 31, 2023 | 280.91M | 67.68M | 31.74% |
| Jan 31, 2022 | 213.23M | 64.56M | 43.42% |
| Jan 31, 2021 | 148.68M | 23.89M | 19.15% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PHR News
- 13 days ago - Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results - Business Wire
- 5 weeks ago - Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling - Business Wire
- 6 weeks ago - Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies - Business Wire
- 2 months ago - Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare - Business Wire
- 2 months ago - Holding Phreesia Despite Initial Post-Earnings Disappointment - Seeking Alpha
- 2 months ago - Phreesia Analysts Raise Their Forecasts After Q2 Results - Benzinga
- 2 months ago - Analysts Weigh Integration Risks As Phreesia Expands With New Deal - Benzinga
- 2 months ago - Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript - Seeking Alpha